Skip to main content

Table 3 Multivariate logistic regression

From: Effect of subclavian vein diameter combined with perioperative fluid therapy on preventing post-induction hypotension in patients with ASA status I or II

 

Unadjusted analysis

Adjusted analysis OR [95% CI]

OR [95% CI]

Model 1

Model 2

Age(years)

1.040 (1.014–1.067) ++

1.031 (0.982–1.082)

1.029 (0.980–1.081)

Sex

   

Male

1.00

1.00

1.00

Female

1.638 (0.851–3.150)

1.081 (0.422–2.767)

1.088 (0.420–2.814)

BMI, kg/m^2

0.960 (0.865–1.065)

0.962 (0.838–1.104)

0.951 (0.827–1.094)

ASA

   

ASA I

1.00

1.00

1.00

ASA II

1.674 (0.866–3.236)

1.054 (0.334–3.324)

1.076 (0.336–3.451)

Albumin, g/L

0.879 (0.811–0.952) ++

0.875 (0.795–0.963) ++

0.873 (0.792–0.962) ++

Baseline MAP, mmHg

0.985 (0.956–1.016)

0.964 (0.922–1.009)

0.966 (0.922–1.011)

Baseline HR, beats/min

1.018 (0.993–1.044)

0.995 (0.959–1.032)

0.994 (0.958–1.032)

dSCVmax; cm

0.071 (0.007–0.706) +

0.806 (0.042–15.621)

—

dSCVmin; cm

0.002 (0-0.028) +++

—

2.158 (0.016-290.968)

SCVCI (%)

1.118 (1.071–1.166) +++

1.119 (1.066–1.173) +++

—

SCVvariability (%)

1.356 (1.213–1.515) +++

—

1.396 (1.154–1.690) ++

  1. +P < 0.05, ++P < 0.01, +++P < 0.001. MAP, mean arterial pressure; HR, heart rate; BMI, body mass index; ASA, American Society of Anesthesiologists physical status; dSCVmax, maximum value of subclavian vein diameter; dSCVmin, minimum value of subclavian vein diameter; SCVCI, subclavian vein collapsibility index; SCVvariability, subclavian vein variability; OR, odds ratio; CI, confidence interval
  2. Model 1: Adjusted for Age, Sex, BMI, ASA physical status, Albumin, Baseline MAP, Baseline HR, dSCVmax and SCVCI.
  3. Model 2: Adjusted for Age, Sex, BMI, ASA physical status, Albumin, Baseline MAP, Baseline HR, dSCVmin and SCVvariability.
Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us